HomeKTTA • NASDAQ
add
Pasithea Therapeutics Corp
Previous close
$1.12
Day range
$1.09 - $1.15
Year range
$0.28 - $3.85
Market cap
25.19M USD
Avg Volume
14.44M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.11M | 3.51% |
Net income | -3.04M | -1.25% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.93M | -3.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.12M | -55.96% |
Total assets | 13.63M | -26.86% |
Total liabilities | 1.42M | 72.82% |
Total equity | 12.21M | — |
Shares outstanding | 7.44M | — |
Price to book | 0.68 | — |
Return on assets | -50.75% | — |
Return on capital | -56.78% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.04M | -1.25% |
Cash from operations | -2.89M | 7.38% |
Cash from investing | — | — |
Cash from financing | -116.14K | -102.56% |
Net change in cash | -2.99M | -314.80% |
Free cash flow | -2.06M | 0.66% |
About
Founded
2020
Headquarters
Website
Employees
4
